SCHEMBL25845438

SCHEMBL25845438

CC(=O)NCCOC(=O)C(C)(C)CC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.38
MTNR1B P49286 4/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HIF1A Q16665 1/20 0.38
TSHR P16473 2/20 0.35
USP2 O75604 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 1/20 0.33
PAOX Q6QHF9 3/20 0.32
ADRA1A P35348 1/20 0.32
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25153643 0.84 POLB (0.35) KDM4E
SCHEMBL19821886 0.84 KDM4E (0.39) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL25846264 0.83 MTNR1A (0.34) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL24144844 0.83 CYP4F2 (0.31)
SCHEMBL19598186 0.83 MTNR1A (0.36) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL21579178 0.81 MAPK1 (0.43) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL19872846 0.80 CYP4F2 (0.35) TSHRALDH1A1GAA
SCHEMBL13585409 0.78 ACHE (0.43) MTNR1AMTNR1BALDH1A1GAAL3MBTL1
SCHEMBL15965828 0.78 MTNR1A (0.43) MTNR1AMTNR1BMAPK1KDM4EHIF1A
SCHEMBL19598411 0.78 ACHE (0.37) MTNR1AMTNR1BALDH1A1GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230201118-A1 PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY THE UNIVERSITY OF CHICAGO 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230201118-A1 PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY SI, VIP, FAAH MTNR1A 1482/4885MTNR1B 2134/4885MAPK1 2935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.